Nasdaq · Healthcare
FORRESTER RESEARCH, INC. (FORR)
As-reported financials and recent SEC filings for FORRESTER RESEARCH, INC., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$396.9M
Net income
$-119.4M
Net margin
-30.1%
Diluted EPS
$-6.28
ROE
-94.3%
P/E (TTM)
—
Market cap
$151.6M
Debt / equity
0.0×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $396.9M | $432.5M | $480.8M | $537.8M | $494.3M |
| Gross profit | $226.2M | $249.9M | $276.3M | $314.0M | $292.5M |
| Operating income | $-113.2M | $740,000 | $6.8M | $32.7M | $38.6M |
| Net income | $-119.4M | $-5.7M | $3.0M | $21.8M | $24.8M |
| Diluted EPS | $-6.28 | $-0.30 | $0.16 | $1.14 | $1.28 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-02
View on EDGAR →42026-06-02
View on EDGAR →42026-06-02
View on EDGAR →SCHEDULE 13G/A2026-05-15
View on EDGAR →8-K2026-05-13
View on EDGAR →42026-05-13
View on EDGAR →42026-05-13
View on EDGAR →42026-05-13
View on EDGAR →Go deeper on FORR
Search FORRESTER RESEARCH, INC.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.